Intercept Pharma 401(k) Plan
Sponsored by Intercept Pharmaceuticals, Inc. · EIN 223868459 · Plan #001
- Total assets
- $50.7M
- Net assets
- $50.7M
- Active participants
- 250
- With balances
- 494
Plan year beginning 01/01/2024 · 401(k)
Linked investment advisers
Advisory firms matched from Schedule C service providers (investment codes 26-28).
| Firm | Match | Plan year |
|---|---|---|
| Merrill Lynch, Pierce, Fenner & Smith Incorporated CRD 7691 | fuzzy_auto · 93% | 2024 |
| Empower Advisory Group, Llc CRD 112058 | deterministic · 100% | 2024 |
Service providers
Schedule C providers paid $5,000+ (large plans only).
| Provider | Services | Direct comp |
|---|---|---|
| Merrill Lynch Pierce Fenner & Smith | Investment advisory (plan) | $94,114 |
| Empower Annuity Insurance Company | Recordkeeping fees | $54,222 |
| Pkf O'connor Davies Llp | Other fees | $8,250 |
| Empower Advisory Group, Llc | Investment management | $7,742 |